| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.41 | 0.02 |